Metagenomi, Moderna terminate gene editing collaboration [Seeking Alpha]
Moderna, Inc. (MRNA)
Last moderna, inc. earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
marinabio.com/investor-relations
Company Research
Source: Seeking Alpha
As a result of the termination, Metagenomi will regain full global rights to its wholly owned gene editing technologies, including base editors and RNA-mediated integration systems. Metagenomi said the termination was the result of Moderna's reprioritization of its programs. Moderna remains a shareholder in the company, Metagenomi added Metagenomi went public in February , raising $94M. After the IPO, Moderna was to have retained a 4.6% stake in Metagenomi, according to an SEC filing, with Bayer ( OTCPK:BAYZF OTCPK:BAYRY ) holding a 10.8% stake. Recommended For You More Trending News Recommended For You More Trending News Related Stocks Trending Analysis Trending News
Show less
Read more
Impact Snapshot
Event Time:
MRNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRNA alerts
High impacting Moderna, Inc. news events
Weekly update
A roundup of the hottest topics
MRNA
News
- OpenAI's marketing head shares the one big mistake CMOs are making with AI [Yahoo! Finance]Yahoo! Finance
- OpenAI's marketing head shares the one big mistake CMOs are making with AI [Fortune]Fortune
- ProofPilot Celebrates Dual Wins with Moderna at Citeline Awards for Best Patient-Facing Technology & Clinical Partnership of the Year [Yahoo! Finance]Yahoo! Finance
- Moderna, Inc. (NASDAQ: MRNA) is now covered by analysts at Evercore ISI. They set an "in-line" rating and a $120.00 price target on the stock.MarketBeat
- 8. ElevateBio [CNBC]CNBC
MRNA
Earnings
- 5/2/24 - Beat
MRNA
Sec Filings
- 5/15/24 - Form 144
- 5/15/24 - Form 144
- 5/13/24 - Form 4
- MRNA's page on the SEC website